Pancreatic Cancer Information Center
Each year in the United States, more than 37,000 people are diagnosed with pancreatic cancer. Pancreatic cancer is often detected at an advanced stage when it is difficult to treat, highlighting the importance of research on prevention and early detection.
Although long-term survival with pancreatic cancer remains poor, researchers continue to explore new approaches to treatment. In addition, advances in supportive care have made pancreatic cancer treatment more tolerable, leading to improved quality of life.
Understanding pancreatic cancer treatment options, the role of different doctors specializing in the treatment of pancreatic cancer, and how and when to access new and innovative pancreatic cancer treatment options available through clinical trials is essential in order to achieve the best outcome from pancreatic cancer treatment.
The Cancer Consultants Pancreatic Cancer Information Center has been designed to help patients understand pancreatic cancer and pancreatic cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of pancreatic cancer.
Headline Pancreatic Cancer News 
Test Holds Promise for Early Detection of Pancreatic Cancer
Detects PAM4 protein in blood.
Processed Meat Linked with Increased Risk of Pancreatic Cancer
Best to limit foods such as sausage and bacon.
CancerConnect Live Web Chat with Dr. Barrie Cassileth from Memorial Sloan-Kettering Cancer Center on Complementary Cancer Therapies on Thursday, November 17th at 6PM EST
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service;...
Pancreatic Cancer Tips
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Preparing for Surgery You can help ensure that your surgery and recovery go smoothly and that you have...
Know the Signs of Depression in Cancer Patients Because a significant number of cancer patients—an estimated 25 percent—experience...
Pancreatic Cancer Management
Inspiration, Hope & Resources
Pancreatic Cancer Action Network By Diana Price Julie Fleshman knows all about the urgent need for hope that grips...
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Pancreatic Cancer Clinical Trials
INST0802 – Phase II Trial of Combination Irinotecan, Oxaliplatin and Cetuximab for Patients with Locally Advanced or Metastatic Pancreatic Cancer
07-111 – A Phase II randomized, double-blind, multicenter trial of Amplimexon plus Gemcitabine versus Gemcitabine plus placebo in patients with metastatic chemotherapy naive pancreatic adenocarcinoma.
MORAb-009 – A Phase 2 Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy of MORAb-009 in Conmbination with Gemcitabine in Patients with Advanced Pancreatic Cancer
 |
 |
 |
 |
